About: BMS-906024     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:Treatment100658082, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FBMS-906024

BMS-906024 is a drug with a benzodiazepine structure, developed by Bristol-Myers Squibb and disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast, lung, colon cancers and leukemia. The drug works as an pan-Notch inhibitor. The structure is one of a set patented in 2012, and is being studied in clinical trials.

AttributesValues
rdf:type
rdfs:label
  • BMS-906024 (en)
  • BMS-906024 (it)
rdfs:comment
  • BMS-906024 is a drug with a benzodiazepine structure, developed by Bristol-Myers Squibb and disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast, lung, colon cancers and leukemia. The drug works as an pan-Notch inhibitor. The structure is one of a set patented in 2012, and is being studied in clinical trials. (en)
  • Il BMS-906024 è uno farmaco con struttura benzodiazepinica sviluppato dalla casa farmaceutica Bristol-Myers Squibb e presentato nella primavera 2013 durante l'American Chemical Society a New Orleans per il trattamento del cancro al seno, ai polmoni, al colon e alla leucemia. Il farmaco funziona come un inibitore di pan-Notch. La struttura fa parte di un insieme brevettato nel 2012, ed è in fase di studio. (it)
foaf:depiction
  • http://commons.wikimedia.org/wiki/Special:FilePath/BMS-906024.svg
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
sameAs
dbp:wikiPageUsesTemplate
thumbnail
c
CAS number
ChemSpiderID
F
H
IUPAC name
  • -N-[-1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-2,3-bissuccinamide (en)
n
O
PubChem
SMILES
  • CN1c2ccccc2Cc3ccccc3 (en)
StdInChI
StdInChIKey
  • AYOUDDAETNMCBW-GSHUGGBRSA-N (en)
UNII
  • DRL23N424R (en)
has abstract
  • BMS-906024 is a drug with a benzodiazepine structure, developed by Bristol-Myers Squibb and disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast, lung, colon cancers and leukemia. The drug works as an pan-Notch inhibitor. The structure is one of a set patented in 2012, and is being studied in clinical trials. (en)
  • Il BMS-906024 è uno farmaco con struttura benzodiazepinica sviluppato dalla casa farmaceutica Bristol-Myers Squibb e presentato nella primavera 2013 durante l'American Chemical Society a New Orleans per il trattamento del cancro al seno, ai polmoni, al colon e alla leucemia. Il farmaco funziona come un inibitore di pan-Notch. La struttura fa parte di un insieme brevettato nel 2012, ed è in fase di studio. (it)
PubChemSubstance
prov:wasDerivedFrom
page length (characters) of wiki page
CAS number
  • 1401066-79-2
FDA UNII code
  • DRL23N424R
PubChem
  • 66550890
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is Wikipage redirect of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 53 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software